PATENT CLAIM ANALYSIS

Application Number: 16130942
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-04
Patent Classification: ["435", "456000"]

Abstract:
Recombinant viral vectors, especially parvovirus vectors such as adeno-associated virus (AAV) vectors, capable of enhanced expression of heterologous sequences, and methods for their construction and use, are provided. The vectors have a structure, or are capable of rapidly adopting a structure, which involves intrastrand base pairing of at least one region in a heterologous sequence.

Claim (Index 43):
The composition of  claim 39 , wherein the heterologous sequence is: (i) a polynucleotide encoding a protein useful in gene therapy to relieve deficiencies caused by missing, defective or sub-optimal levels of a structural protein or enzyme; (ii) a polynucleotide that is transcribed into an anti-sense molecule; (iii) a polynucleotide that is transcribed into a decoy that binds a transcription or translation factor, (iv) a polynucleotide that encodes a cellular modulator; (v) a polynucleotide that can make a recipient cell susceptible to a specific drug; (vi) a polynucleotide for cancer therapy; or (vii) a polynucleotide that encodes an antigen or antibody.

Metadata:
- Claim Count in Document: 17.0
- Percentile: 97.0
- Lexical Diversity: 1.41304
- Patent Class: 435.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['10423507', '12910711', '11514820', '11890656', '09684554']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7322295119559769
- 35 USC 102 Novelty (BERT): 0.668108717287496
- Combined Prediction Score: 0.7258174324891288
- Mean Citation Score: 634.686972
- Max Citation Score: 689.5589
- Similarity Product: 633.9921092735767

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test